Erica L Buonomo
Overview
Explore the profile of Erica L Buonomo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
555
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Buonomo E, Mei S, Guinn S, Leo I, Peluso M, Nolan M, et al.
J Hepatol
. 2022 Jan;
76(5):1127-1137.
PMID: 35074474
Background & Aims: Myeloid cells are key regulators of cirrhosis, a major cause of mortality worldwide. Because stromal cells can modulate the functionality of myeloid cells in vitro, targeting stromal-myeloid...
2.
IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection
Frisbee A, Saleh M, Young M, Leslie J, Simpson M, Abhyankar M, et al.
Nat Commun
. 2019 Jun;
10(1):2712.
PMID: 31221971
Clostridium difficile (C. difficile) incidence has tripled over the past 15 years and is attributed to the emergence of hypervirulent strains. While it is clear that C. difficile toxins cause...
3.
Saleh M, Frisbee A, Leslie J, Buonomo E, Cowardin C, Ma J, et al.
Cell Host Microbe
. 2019 Apr;
25(5):756-765.e5.
PMID: 31003940
Clostridium difficile infection (CDI) is the number one hospital-acquired infection in the United States. CDI is more common and severe in inflammatory bowel disease patients. Here, we studied the mechanism...
4.
Interest of Eosinophil Count in Bacterial Infections to Predict Antimicrobial Therapy Efficacy-Reply
Kulaylat A, Buonomo E, Stewart D
JAMA Surg
. 2019 Feb;
154(5):464-465.
PMID: 30758488
No abstract available.
5.
Kulaylat A, Buonomo E, Scully K, Hollenbeak C, Cook H, Petri Jr W, et al.
JAMA Surg
. 2018 Sep;
153(12):1127-1133.
PMID: 30208386
Importance: Recent evidence from an animal model suggests that peripheral loss of eosinophils in Clostridium difficile infection (CDI) is associated with severe disease. The ability to identify high-risk patients with...
6.
Noor Z, Watanabe K, Abhyankar M, Burgess S, Buonomo E, Cowardin C, et al.
mBio
. 2017 Mar;
8(1).
PMID: 28246365
The parasite is a cause of diarrhea in infants in low-income countries. Previously, it was shown that tumor necrosis factor alpha (TNF-α) production was associated with increased risk of diarrhea...
7.
Cowardin C, Buonomo E, Saleh M, Wilson M, Burgess S, Kuehne S, et al.
Nat Microbiol
. 2016 Aug;
1(8):16108.
PMID: 27573114
Clostridium difficile is the most common hospital acquired pathogen in the USA, and infection is, in many cases, fatal. Toxins A and B are its major virulence factors, but expression...
8.
Buonomo E, Cowardin C, Wilson M, Saleh M, Pramoonjago P, Petri Jr W
Cell Rep
. 2016 Jun;
16(2):432-443.
PMID: 27346351
Clostridium difficile infection (CDI) is the most common cause of hospital-acquired infection in the United States. Host susceptibility and the severity of infection are influenced by disruption of the microbiota...
9.
Buonomo E, Petri Jr W
Anaerobe
. 2016 May;
41:79-84.
PMID: 27212111
Clostridium difficile is a gram-positive, spore forming anaerobe that infects the gut when the normal microbiota has been disrupted. C. difficile infection (CDI) is the most common cause of hospital...
10.
Buonomo E, Petri Jr W
Cell Host Microbe
. 2015 Jul;
18(1):5-6.
PMID: 26159713
The contribution of the innate immune response to the resolution of Clostridium difficile infection (CDI) remains incompletely defined. In this issue of Cell Host & Microbe, Abt et al. demonstrated...